21세기 치유법 법안과 FDA 지침 이후 의료 경제적 정보 및 사전 승인 정보를 의료 결정자들에게 전달하는 방법: 기회

초록

With rising US healthcare costs, population health decision-makers have expressed interest in receiving pre-approval information to help with the budgeting and forecasting needed to accommodate pharmaceutical and medical device launches. Additionally, there has been a strong emphasis placed on the economics and quality of new products. Manufacturers have historically been reluctant to share pre-approval or healthcare economic information (HCEI) due to unclear regulatory guidance for these types